CYCLACEL PHARMACEUTICALS INC (CYCC)

Overview Price 0.65 Price Change Today -$0.01 (-1.52%) P&P rating Zacks Rank 3 - HOLD Open Price $0.68 Previous Close $0.66 Daily Range $0.63 - $0.68 52-Week Range $0.36 - $1.84 Volume 338,877 CYCLACEL is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and cutaneous T-cell lymphoma. Seliciclib (CYC202 or R-roscovitine), a CDK inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer. Other Resources for CYCC Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Zacks #1 Rank Additions for Friday November 18, 2011 CYCLACEL is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and cutaneous T-cell lymphoma. Seliciclib (CYC202 or R-roscovitine), a CDK inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer.   Brokerage Analyst Recommendations 3 Brokerage Firms Covering CYCC   Strong Buy 2 Buy 0 Hold 1 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1.67   CYCC Ratings: BUY  SELL  HOLD CYCC Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 1 Buy 1 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	05/14/10	Cyclacel Losses Widen - Analyst Blog	0
Zacks_Analysts	0.00	03/24/10	Cyclacel Posts Wider Loss - Analyst Blog	0
Zacks_Analysts	0.00	07/27/09	Cyclacel Raising Money - Analyst Blog	0
Zacks_Analysts	0.00	06/18/09	Cyclacel Conserving Resources - Analyst Blog	0

Commentary

BUY: CYCLACEL PHARMACEUTICALS INC. (CYCC) Start Price: $7.42 Points: -83.32 Created: 01/01/2008 Comments: 0 | Comment THESPARK Recs:

SELL: CYCLACEL PHARMACEUTICALS INC. (CYCC) Start Price: $8.05 Points: +84.00 Created: 01/01/2008 Comments: 0 | Comment mickmcmahon Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
THESPARK		BUY	Six Months to a Year	01/01/2008	$7.42	$0.65 (+1.88%)	-91.24%	-7.92%	-83.32
mickmcmahon	92.04	SELL	Six Months to a Year	01/01/2008	$8.05	$0.65 (+1.88%)	-91.93%	-7.92%	+84.00